Fonte: Clinical Therapeutics. Unidades: FCF, FM
Assuntos: QUEIMADURAS, FARMACODINÂMICA, FARMACOCINÉTICA, SEPSE
ABNT
MESSIANO, Claudia Garcia et al. Therapeutic target attainment of 3-Hour extended Infusion of Meropenem in patients with septic burns. Clinical Therapeutics, v. 44, p. 624-629, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.clinthera.2022.02.007. Acesso em: 06 set. 2024.APA
Messiano, C. G., Morales Júnior, R., Pereira, G. O., Silva Junior, E. M. da, Gomez, D. de S., & Santos, S. R. C. J. (2022). Therapeutic target attainment of 3-Hour extended Infusion of Meropenem in patients with septic burns. Clinical Therapeutics, 44, 624-629. doi:10.1016/j.clinthera.2022.02.007NLM
Messiano CG, Morales Júnior R, Pereira GO, Silva Junior EM da, Gomez D de S, Santos SRCJ. Therapeutic target attainment of 3-Hour extended Infusion of Meropenem in patients with septic burns [Internet]. Clinical Therapeutics. 2022 ; 44 624-629.[citado 2024 set. 06 ] Available from: https://doi.org/10.1016/j.clinthera.2022.02.007Vancouver
Messiano CG, Morales Júnior R, Pereira GO, Silva Junior EM da, Gomez D de S, Santos SRCJ. Therapeutic target attainment of 3-Hour extended Infusion of Meropenem in patients with septic burns [Internet]. Clinical Therapeutics. 2022 ; 44 624-629.[citado 2024 set. 06 ] Available from: https://doi.org/10.1016/j.clinthera.2022.02.007